(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|
Turnover | 2.18%132.05M | 4.36%573.14M | 6.98%409.83M | --129.23M | 17.81%549.22M | --383.11M | --466.18M |
Operating income | 2.18%132.05M | 4.36%573.14M | 6.98%409.83M | 129.23M | 17.81%549.22M | 383.11M | 466.18M |
Cost of sales | 9.04%-82.54M | -8.33%-394.14M | -12.04%-286.25M | ---90.74M | -20.53%-363.81M | ---255.48M | ---301.85M |
Operating expenses | 9.04%-82.54M | -8.33%-394.14M | -12.04%-286.25M | -90.74M | -20.53%-363.81M | -255.48M | -301.85M |
Gross profit | 28.64%49.52M | -3.45%179M | -3.17%123.59M | 38.49M | 12.82%185.4M | 127.63M | 164.33M |
Selling expenses | 40.00%-24.35M | 18.67%-150.21M | 19.76%-111.23M | ---40.58M | -2.98%-184.68M | ---138.62M | ---179.33M |
Administrative expenses | -156.74%-135.29M | 6.99%-268.91M | 10.83%-183M | ---52.7M | -8.33%-289.12M | ---205.22M | ---266.89M |
Research and development expenses | 48.50%-27.16M | 18.73%-169.19M | 2.57%-137.37M | ---52.74M | -9.08%-208.18M | ---141M | ---190.84M |
Impairment and provision | 90.91%-1.05M | 29.99%-17.97M | -585.86%-18.24M | ---11.57M | 55.98%-25.67M | ---2.66M | ---58.32M |
-Impairment of intangible assets | ---- | 57.23%-9.57M | -186.67%-9.57M | ---9.57M | 58.62%-22.38M | ---3.34M | ---54.09M |
-Other impairment is provision | 47.29%-1.05M | -155.22%-8.4M | -1,377.17%-8.67M | ---1.99M | 22.17%-3.29M | --679K | ---4.23M |
Special items of operating profit | 440.48%11.64M | -61.37%30.7M | -63.06%32.06M | --2.15M | 212.55%79.46M | --86.81M | --25.42M |
Operating profit | -8.34%-126.69M | 10.43%-396.59M | -7.74%-294.2M | -116.94M | 12.43%-442.78M | -273.07M | -505.63M |
Financing income | -14.16%8.63M | 82.02%41.65M | 38.79%26.6M | --10.05M | -20.37%22.88M | --19.17M | --28.74M |
Financing cost | 70.82%-157K | 46.62%-1.43M | 43.49%-1.19M | ---538K | 1.03%-2.68M | ---2.11M | ---2.71M |
Earning before tax | -10.05%-118.22M | 15.67%-356.36M | -4.99%-268.79M | -107.42M | 11.89%-422.58M | -256.01M | -479.61M |
Tax | ---- | ---15K | ---15K | ---- | ---- | ---- | ---6K |
After-tax profit from continuing operations | -10.05%-118.22M | 15.67%-356.38M | -5.00%-268.81M | -107.42M | 11.89%-422.58M | -256.01M | -479.61M |
Earning after tax | -10.05%-118.22M | 15.67%-356.38M | -5.00%-268.81M | -107.42M | 11.89%-422.58M | -256.01M | -479.61M |
Minority profit | 42.39%-1.95M | 0.75%-9.6M | -195.22%-7.29M | ---3.38M | ---9.67M | ---2.47M | ---- |
Profit attributable to shareholders | -11.76%-116.28M | 16.02%-346.78M | -3.14%-261.51M | -104.04M | 13.91%-412.91M | -253.54M | -479.61M |
Basic earnings per share | -15.79%-0.22 | 16.88%-0.64 | -4.26%-0.49 | -0.19 | 13.48%-0.77 | -0.47 | -0.89 |
Diluted earnings per share | -15.79%-0.22 | 16.88%-0.64 | -4.26%-0.49 | -0.19 | 13.48%-0.77 | -0.47 | -0.89 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data